Disease: Glioma ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0017638
Disease: Glioma
Glioma 		0.370 Biomarker disease BEFREE SIRT1 inhibition increased the sensitivity of glioma cells for TMZ via the facilitation of intracellular ROS generation, which suggested that SIRT1 may serve as a target for clinical therapy of glioma. 31186751 2019
CUI: C0017638
Disease: Glioma
Glioma 		0.370 Biomarker disease BEFREE Our case and others suggest that various ROS1 fusions might be present in a subset of pediatric gliomas, which could be targeted for therapy. 30350109 2019
CUI: C0017638
Disease: Glioma
Glioma 		0.370 Biomarker disease BEFREE ROS generation and autophagosome accumulation contribute to the DMAMCL-induced inhibition of glioma cell proliferation by regulating the ROS/MAPK signaling pathway and suppressing the Akt/mTOR signaling pathway. 30881039 2019
CUI: C0017638
Disease: Glioma
Glioma 		0.370 Biomarker disease BEFREE Ampelopsin inhibits human glioma through inducing apoptosis and autophagy dependent on ROS generation and JNK pathway. 31108349 2019
CUI: C0017638
Disease: Glioma
Glioma 		0.370 Biomarker disease BEFREE Rare but Recurrent ROS1 Fusions Resulting From Chromosome 6q22 Microdeletions are Targetable Oncogenes in Glioma. 30171048 2018
CUI: C0017638
Disease: Glioma
Glioma 		0.370 Biomarker disease BEFREE β-Lapachone-induced reactive oxygen species (ROS) generation mediates autophagic cell death in glioma U87 MG cells. 21035436 2011
CUI: C0017638
Disease: Glioma
Glioma 		0.370 AlteredExpression disease BEFREE These results establish a strong link between c-ROS promoter demethylation and gain of c-ROS expression and function in glioma. 19276365 2009
CUI: C0017638
Disease: Glioma
Glioma 		0.370 Biomarker disease CTD_human These results establish a strong link between c-ROS promoter demethylation and gain of c-ROS expression and function in glioma. 19276365 2009